nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—Diphenhydramine—atopic dermatitis	0.376	1	CrCtD
Methadone—CYP2C18—Diphenhydramine—atopic dermatitis	0.0312	0.119	CbGbCtD
Methadone—Modafinil—Dimenhydrinate—atopic dermatitis	0.0186	0.0656	CrCrCtD
Methadone—Oxaprozin—Diphenhydramine—atopic dermatitis	0.015	0.053	CrCrCtD
Methadone—Phenylbutazone—Diphenhydramine—atopic dermatitis	0.0144	0.0508	CrCrCtD
Methadone—CYP19A1—Betamethasone—atopic dermatitis	0.0142	0.0541	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0142	0.0538	CbGbCtD
Methadone—CYP3A7—Tacrolimus—atopic dermatitis	0.0142	0.0538	CbGbCtD
Methadone—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.014	0.0493	CrCrCtD
Methadone—Alverine—Diphenhydramine—atopic dermatitis	0.0138	0.0487	CrCrCtD
Methadone—Isopropamide—Diphenhydramine—atopic dermatitis	0.0138	0.0487	CrCrCtD
Methadone—CYP2C8—Mometasone—atopic dermatitis	0.013	0.0495	CbGbCtD
Methadone—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0124	0.0438	CrCrCtD
Methadone—Tamoxifen—Diphenhydramine—atopic dermatitis	0.012	0.0421	CrCrCtD
Methadone—Eprazinone—Diphenhydramine—atopic dermatitis	0.012	0.0421	CrCrCtD
Methadone—Antazoline—Diphenhydramine—atopic dermatitis	0.012	0.0421	CrCrCtD
Methadone—Levomethadyl Acetate—Diphenhydramine—atopic dermatitis	0.0116	0.0408	CrCrCtD
Methadone—Methadyl Acetate—Diphenhydramine—atopic dermatitis	0.0116	0.0408	CrCrCtD
Methadone—CYP3A5—Tacrolimus—atopic dermatitis	0.0106	0.0404	CbGbCtD
Methadone—Doxylamine—Diphenhydramine—atopic dermatitis	0.01	0.0352	CrCrCtD
Methadone—CYP2B6—Diphenhydramine—atopic dermatitis	0.00988	0.0375	CbGbCtD
Methadone—Dextropropoxyphene—Diphenhydramine—atopic dermatitis	0.0095	0.0334	CrCrCtD
Methadone—Phenoxybenzamine—Diphenhydramine—atopic dermatitis	0.0095	0.0334	CrCrCtD
Methadone—Atomoxetine—Diphenhydramine—atopic dermatitis	0.00905	0.0319	CrCrCtD
Methadone—Tripelennamine—Diphenhydramine—atopic dermatitis	0.00905	0.0319	CrCrCtD
Methadone—Trimipramine—Diphenhydramine—atopic dermatitis	0.00884	0.0311	CrCrCtD
Methadone—Modafinil—Diphenhydramine—atopic dermatitis	0.00884	0.0311	CrCrCtD
Methadone—Fentanyl—Diphenhydramine—atopic dermatitis	0.00846	0.0298	CrCrCtD
Methadone—CYP19A1—Dexamethasone—atopic dermatitis	0.00829	0.0315	CbGbCtD
Methadone—Pheniramine—Diphenhydramine—atopic dermatitis	0.00828	0.0292	CrCrCtD
Methadone—Promethazine—Diphenhydramine—atopic dermatitis	0.0075	0.0264	CrCrCtD
Methadone—CYP2C8—Loratadine—atopic dermatitis	0.00748	0.0284	CbGbCtD
Methadone—Alimemazine—Diphenhydramine—atopic dermatitis	0.00736	0.0259	CrCrCtD
Methadone—CYP3A4—Pimecrolimus—atopic dermatitis	0.00697	0.0265	CbGbCtD
Methadone—ABCB1—Tacrolimus—atopic dermatitis	0.00692	0.0263	CbGbCtD
Methadone—Clofedanol—Diphenhydramine—atopic dermatitis	0.00687	0.0242	CrCrCtD
Methadone—Orphenadrine—Diphenhydramine—atopic dermatitis	0.00665	0.0234	CrCrCtD
Methadone—Benzphetamine—Diphenhydramine—atopic dermatitis	0.00665	0.0234	CrCrCtD
Methadone—CYP2C19—Loratadine—atopic dermatitis	0.00628	0.0238	CbGbCtD
Methadone—CYP2C19—Diphenhydramine—atopic dermatitis	0.00628	0.0238	CbGbCtD
Methadone—Benzyl Benzoate—Diphenhydramine—atopic dermatitis	0.00616	0.0217	CrCrCtD
Methadone—CYP1A2—Diphenhydramine—atopic dermatitis	0.00579	0.022	CbGbCtD
Methadone—CYP3A7—Hydrocortisone—atopic dermatitis	0.00577	0.0219	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00577	0.0219	CbGbCtD
Methadone—CYP2C9—Diphenhydramine—atopic dermatitis	0.00522	0.0198	CbGbCtD
Methadone—CYP2C9—Loratadine—atopic dermatitis	0.00522	0.0198	CbGbCtD
Methadone—ABCB1—Loratadine—atopic dermatitis	0.00507	0.0192	CbGbCtD
Methadone—CYP2D6—Loratadine—atopic dermatitis	0.00477	0.0181	CbGbCtD
Methadone—CYP2D6—Diphenhydramine—atopic dermatitis	0.00477	0.0181	CbGbCtD
Methadone—ABCB1—Methylprednisolone—atopic dermatitis	0.00463	0.0176	CbGbCtD
Methadone—CYP3A5—Hydrocortisone—atopic dermatitis	0.00433	0.0164	CbGbCtD
Methadone—CYP2C8—Hydrocortisone—atopic dermatitis	0.00416	0.0158	CbGbCtD
Methadone—CYP3A4—Tacrolimus—atopic dermatitis	0.00415	0.0157	CbGbCtD
Methadone—CYP3A7—Dexamethasone—atopic dermatitis	0.00359	0.0136	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00359	0.0136	CbGbCtD
Methadone—CYP2C19—Prednisone—atopic dermatitis	0.00348	0.0132	CbGbCtD
Methadone—CYP2B6—Dexamethasone—atopic dermatitis	0.00342	0.013	CbGbCtD
Methadone—CYP3A4—Loratadine—atopic dermatitis	0.00303	0.0115	CbGbCtD
Methadone—ABCB1—Betamethasone—atopic dermatitis	0.00301	0.0114	CbGbCtD
Methadone—ABCB1—Prednisolone—atopic dermatitis	0.00297	0.0113	CbGbCtD
Methadone—ABCB1—Hydrocortisone—atopic dermatitis	0.00282	0.0107	CbGbCtD
Methadone—ABCB1—Prednisone—atopic dermatitis	0.00281	0.0107	CbGbCtD
Methadone—CYP3A4—Methylprednisolone—atopic dermatitis	0.00278	0.0105	CbGbCtD
Methadone—CYP3A5—Dexamethasone—atopic dermatitis	0.00269	0.0102	CbGbCtD
Methadone—CYP2C8—Dexamethasone—atopic dermatitis	0.00259	0.00983	CbGbCtD
Methadone—CYP2C19—Dexamethasone—atopic dermatitis	0.00217	0.00824	CbGbCtD
Methadone—CYP3A4—Triamcinolone—atopic dermatitis	0.0021	0.00798	CbGbCtD
Methadone—CYP2C9—Dexamethasone—atopic dermatitis	0.00181	0.00685	CbGbCtD
Methadone—CYP3A4—Betamethasone—atopic dermatitis	0.0018	0.00685	CbGbCtD
Methadone—CYP3A4—Prednisolone—atopic dermatitis	0.00178	0.00676	CbGbCtD
Methadone—ABCB1—Dexamethasone—atopic dermatitis	0.00175	0.00665	CbGbCtD
Methadone—CYP3A4—Hydrocortisone—atopic dermatitis	0.00169	0.00641	CbGbCtD
Methadone—CYP3A4—Prednisone—atopic dermatitis	0.00168	0.00638	CbGbCtD
Methadone—CYP2D6—Dexamethasone—atopic dermatitis	0.00165	0.00627	CbGbCtD
Methadone—CYP3A4—Dexamethasone—atopic dermatitis	0.00105	0.00398	CbGbCtD
Methadone—CHRNA10—ear—atopic dermatitis	0.000671	0.562	CbGeAlD
Methadone—CHRNA10—head—atopic dermatitis	0.0001	0.0839	CbGeAlD
Methadone—GRIN3A—head—atopic dermatitis	8.86e-05	0.0741	CbGeAlD
Methadone—Pain—Tacrolimus—atopic dermatitis	6.84e-05	0.00101	CcSEcCtD
Methadone—Constipation—Tacrolimus—atopic dermatitis	6.84e-05	0.00101	CcSEcCtD
Methadone—Weight increased—Dexamethasone—atopic dermatitis	6.82e-05	0.001	CcSEcCtD
Methadone—Weight increased—Betamethasone—atopic dermatitis	6.82e-05	0.001	CcSEcCtD
Methadone—Weight decreased—Betamethasone—atopic dermatitis	6.78e-05	0.000999	CcSEcCtD
Methadone—Weight decreased—Dexamethasone—atopic dermatitis	6.78e-05	0.000999	CcSEcCtD
Methadone—Bradycardia—Triamcinolone—atopic dermatitis	6.73e-05	0.000992	CcSEcCtD
Methadone—Bradycardia—Methylprednisolone—atopic dermatitis	6.71e-05	0.000989	CcSEcCtD
Methadone—Vomiting—Fluocinolone Acetonide—atopic dermatitis	6.69e-05	0.000986	CcSEcCtD
Methadone—Rash—Fluocinolone Acetonide—atopic dermatitis	6.63e-05	0.000977	CcSEcCtD
Methadone—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	6.63e-05	0.000977	CcSEcCtD
Methadone—Headache—Fluocinolone Acetonide—atopic dermatitis	6.59e-05	0.000971	CcSEcCtD
Methadone—Feeling abnormal—Tacrolimus—atopic dermatitis	6.59e-05	0.000971	CcSEcCtD
Methadone—Hallucination—Methylprednisolone—atopic dermatitis	6.56e-05	0.000967	CcSEcCtD
Methadone—Gastrointestinal pain—Tacrolimus—atopic dermatitis	6.54e-05	0.000963	CcSEcCtD
Methadone—Arrhythmia—Prednisolone—atopic dermatitis	6.42e-05	0.000946	CcSEcCtD
Methadone—Vomiting—Mometasone—atopic dermatitis	6.39e-05	0.000941	CcSEcCtD
Methadone—Sweating increased—Prednisone—atopic dermatitis	6.35e-05	0.000937	CcSEcCtD
Methadone—Visual impairment—Methylprednisolone—atopic dermatitis	6.35e-05	0.000937	CcSEcCtD
Methadone—Urticaria—Tacrolimus—atopic dermatitis	6.35e-05	0.000936	CcSEcCtD
Methadone—Rash—Mometasone—atopic dermatitis	6.33e-05	0.000933	CcSEcCtD
Methadone—Dermatitis—Mometasone—atopic dermatitis	6.33e-05	0.000933	CcSEcCtD
Methadone—Abdominal pain—Tacrolimus—atopic dermatitis	6.32e-05	0.000931	CcSEcCtD
Methadone—Body temperature increased—Tacrolimus—atopic dermatitis	6.32e-05	0.000931	CcSEcCtD
Methadone—Headache—Mometasone—atopic dermatitis	6.29e-05	0.000927	CcSEcCtD
Methadone—Arrhythmia—Hydrocortisone—atopic dermatitis	6.27e-05	0.000924	CcSEcCtD
Methadone—Erythema—Prednisolone—atopic dermatitis	6.26e-05	0.000922	CcSEcCtD
Methadone—Nausea—Fluocinolone Acetonide—atopic dermatitis	6.25e-05	0.000921	CcSEcCtD
Methadone—OPRD1—head—atopic dermatitis	6.24e-05	0.0522	CbGeAlD
Methadone—Erythema—Hydrocortisone—atopic dermatitis	6.11e-05	0.000901	CcSEcCtD
Methadone—Bradycardia—Betamethasone—atopic dermatitis	6.1e-05	0.0009	CcSEcCtD
Methadone—Bradycardia—Dexamethasone—atopic dermatitis	6.1e-05	0.0009	CcSEcCtD
Methadone—OPRK1—head—atopic dermatitis	5.98e-05	0.0501	CbGeAlD
Methadone—Hallucination—Betamethasone—atopic dermatitis	5.97e-05	0.000879	CcSEcCtD
Methadone—Hallucination—Dexamethasone—atopic dermatitis	5.97e-05	0.000879	CcSEcCtD
Methadone—Nausea—Mometasone—atopic dermatitis	5.97e-05	0.000879	CcSEcCtD
Methadone—Weight increased—Prednisone—atopic dermatitis	5.94e-05	0.000875	CcSEcCtD
Methadone—Arrhythmia—Triamcinolone—atopic dermatitis	5.9e-05	0.00087	CcSEcCtD
Methadone—Weight decreased—Prednisone—atopic dermatitis	5.9e-05	0.00087	CcSEcCtD
Methadone—Arrhythmia—Methylprednisolone—atopic dermatitis	5.89e-05	0.000868	CcSEcCtD
Methadone—Hypersensitivity—Tacrolimus—atopic dermatitis	5.89e-05	0.000868	CcSEcCtD
Methadone—Visual impairment—Betamethasone—atopic dermatitis	5.78e-05	0.000852	CcSEcCtD
Methadone—Visual impairment—Dexamethasone—atopic dermatitis	5.78e-05	0.000852	CcSEcCtD
Methadone—Erythema—Triamcinolone—atopic dermatitis	5.75e-05	0.000848	CcSEcCtD
Methadone—Erythema—Methylprednisolone—atopic dermatitis	5.74e-05	0.000846	CcSEcCtD
Methadone—Asthenia—Tacrolimus—atopic dermatitis	5.73e-05	0.000845	CcSEcCtD
Methadone—Pruritus—Tacrolimus—atopic dermatitis	5.65e-05	0.000834	CcSEcCtD
Methadone—Vertigo—Prednisolone—atopic dermatitis	5.62e-05	0.000828	CcSEcCtD
Methadone—Syncope—Prednisolone—atopic dermatitis	5.61e-05	0.000827	CcSEcCtD
Methadone—Loss of consciousness—Prednisolone—atopic dermatitis	5.5e-05	0.00081	CcSEcCtD
Methadone—Vertigo—Hydrocortisone—atopic dermatitis	5.49e-05	0.000809	CcSEcCtD
Methadone—Syncope—Hydrocortisone—atopic dermatitis	5.48e-05	0.000808	CcSEcCtD
Methadone—Diarrhoea—Tacrolimus—atopic dermatitis	5.47e-05	0.000806	CcSEcCtD
Methadone—Convulsion—Prednisolone—atopic dermatitis	5.42e-05	0.000799	CcSEcCtD
Methadone—Loss of consciousness—Hydrocortisone—atopic dermatitis	5.37e-05	0.000792	CcSEcCtD
Methadone—Arrhythmia—Betamethasone—atopic dermatitis	5.36e-05	0.00079	CcSEcCtD
Methadone—Arrhythmia—Dexamethasone—atopic dermatitis	5.36e-05	0.00079	CcSEcCtD
Methadone—Bradycardia—Prednisone—atopic dermatitis	5.32e-05	0.000784	CcSEcCtD
Methadone—Convulsion—Hydrocortisone—atopic dermatitis	5.29e-05	0.00078	CcSEcCtD
Methadone—Dizziness—Tacrolimus—atopic dermatitis	5.29e-05	0.000779	CcSEcCtD
Methadone—Erythema—Dexamethasone—atopic dermatitis	5.22e-05	0.000769	CcSEcCtD
Methadone—Erythema—Betamethasone—atopic dermatitis	5.22e-05	0.000769	CcSEcCtD
Methadone—Hallucination—Prednisone—atopic dermatitis	5.2e-05	0.000766	CcSEcCtD
Methadone—Anxiety—Hydrocortisone—atopic dermatitis	5.18e-05	0.000764	CcSEcCtD
Methadone—Vertigo—Triamcinolone—atopic dermatitis	5.17e-05	0.000762	CcSEcCtD
Methadone—Syncope—Triamcinolone—atopic dermatitis	5.16e-05	0.00076	CcSEcCtD
Methadone—Vertigo—Methylprednisolone—atopic dermatitis	5.16e-05	0.00076	CcSEcCtD
Methadone—Syncope—Methylprednisolone—atopic dermatitis	5.15e-05	0.000759	CcSEcCtD
Methadone—Oedema—Prednisolone—atopic dermatitis	5.11e-05	0.000753	CcSEcCtD
Methadone—Anaphylactic shock—Prednisolone—atopic dermatitis	5.11e-05	0.000753	CcSEcCtD
Methadone—Vomiting—Tacrolimus—atopic dermatitis	5.08e-05	0.000749	CcSEcCtD
Methadone—Loss of consciousness—Triamcinolone—atopic dermatitis	5.06e-05	0.000745	CcSEcCtD
Methadone—Loss of consciousness—Methylprednisolone—atopic dermatitis	5.04e-05	0.000744	CcSEcCtD
Methadone—Rash—Tacrolimus—atopic dermatitis	5.04e-05	0.000743	CcSEcCtD
Methadone—Dermatitis—Tacrolimus—atopic dermatitis	5.04e-05	0.000742	CcSEcCtD
Methadone—Shock—Prednisolone—atopic dermatitis	5.02e-05	0.00074	CcSEcCtD
Methadone—Headache—Tacrolimus—atopic dermatitis	5.01e-05	0.000738	CcSEcCtD
Methadone—Oedema—Hydrocortisone—atopic dermatitis	4.99e-05	0.000735	CcSEcCtD
Methadone—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.99e-05	0.000735	CcSEcCtD
Methadone—Convulsion—Triamcinolone—atopic dermatitis	4.98e-05	0.000735	CcSEcCtD
Methadone—Tachycardia—Prednisolone—atopic dermatitis	4.98e-05	0.000734	CcSEcCtD
Methadone—Convulsion—Methylprednisolone—atopic dermatitis	4.97e-05	0.000733	CcSEcCtD
Methadone—Hyperhidrosis—Prednisolone—atopic dermatitis	4.94e-05	0.000728	CcSEcCtD
Methadone—Shock—Hydrocortisone—atopic dermatitis	4.91e-05	0.000723	CcSEcCtD
Methadone—Anxiety—Methylprednisolone—atopic dermatitis	4.87e-05	0.000718	CcSEcCtD
Methadone—Tachycardia—Hydrocortisone—atopic dermatitis	4.87e-05	0.000717	CcSEcCtD
Methadone—Flushing—Prednisone—atopic dermatitis	4.85e-05	0.000714	CcSEcCtD
Methadone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.82e-05	0.000711	CcSEcCtD
Methadone—Dry mouth—Triamcinolone—atopic dermatitis	4.79e-05	0.000706	CcSEcCtD
Methadone—Anorexia—Hydrocortisone—atopic dermatitis	4.75e-05	0.000701	CcSEcCtD
Methadone—Nausea—Tacrolimus—atopic dermatitis	4.75e-05	0.0007	CcSEcCtD
Methadone—Confusional state—Methylprednisolone—atopic dermatitis	4.72e-05	0.000696	CcSEcCtD
Methadone—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.69e-05	0.000692	CcSEcCtD
Methadone—Oedema—Triamcinolone—atopic dermatitis	4.69e-05	0.000692	CcSEcCtD
Methadone—Vertigo—Dexamethasone—atopic dermatitis	4.69e-05	0.000691	CcSEcCtD
Methadone—Vertigo—Betamethasone—atopic dermatitis	4.69e-05	0.000691	CcSEcCtD
Methadone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.68e-05	0.000691	CcSEcCtD
Methadone—Syncope—Betamethasone—atopic dermatitis	4.68e-05	0.00069	CcSEcCtD
Methadone—Syncope—Dexamethasone—atopic dermatitis	4.68e-05	0.00069	CcSEcCtD
Methadone—Arrhythmia—Prednisone—atopic dermatitis	4.66e-05	0.000688	CcSEcCtD
Methadone—Hypotension—Hydrocortisone—atopic dermatitis	4.66e-05	0.000687	CcSEcCtD
Methadone—HTR3A—head—atopic dermatitis	4.64e-05	0.0389	CbGeAlD
Methadone—Shock—Triamcinolone—atopic dermatitis	4.62e-05	0.000681	CcSEcCtD
Methadone—Insomnia—Prednisolone—atopic dermatitis	4.62e-05	0.000681	CcSEcCtD
Methadone—Shock—Methylprednisolone—atopic dermatitis	4.61e-05	0.000679	CcSEcCtD
Methadone—Loss of consciousness—Dexamethasone—atopic dermatitis	4.59e-05	0.000676	CcSEcCtD
Methadone—Loss of consciousness—Betamethasone—atopic dermatitis	4.59e-05	0.000676	CcSEcCtD
Methadone—Tachycardia—Triamcinolone—atopic dermatitis	4.58e-05	0.000675	CcSEcCtD
Methadone—Tachycardia—Methylprednisolone—atopic dermatitis	4.57e-05	0.000674	CcSEcCtD
Methadone—Erythema—Prednisone—atopic dermatitis	4.55e-05	0.00067	CcSEcCtD
Methadone—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.54e-05	0.000669	CcSEcCtD
Methadone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.53e-05	0.000668	CcSEcCtD
Methadone—Convulsion—Betamethasone—atopic dermatitis	4.52e-05	0.000667	CcSEcCtD
Methadone—Convulsion—Dexamethasone—atopic dermatitis	4.52e-05	0.000667	CcSEcCtD
Methadone—Insomnia—Hydrocortisone—atopic dermatitis	4.51e-05	0.000665	CcSEcCtD
Methadone—Anxiety—Betamethasone—atopic dermatitis	4.43e-05	0.000653	CcSEcCtD
Methadone—Anxiety—Dexamethasone—atopic dermatitis	4.43e-05	0.000653	CcSEcCtD
Methadone—Hypotension—Methylprednisolone—atopic dermatitis	4.38e-05	0.000645	CcSEcCtD
Methadone—Pain—Prednisolone—atopic dermatitis	4.37e-05	0.000644	CcSEcCtD
Methadone—Decreased appetite—Hydrocortisone—atopic dermatitis	4.33e-05	0.000639	CcSEcCtD
Methadone—Pain—Hydrocortisone—atopic dermatitis	4.26e-05	0.000629	CcSEcCtD
Methadone—Anaphylactic shock—Betamethasone—atopic dermatitis	4.26e-05	0.000628	CcSEcCtD
Methadone—Anaphylactic shock—Dexamethasone—atopic dermatitis	4.26e-05	0.000628	CcSEcCtD
Methadone—Oedema—Betamethasone—atopic dermatitis	4.26e-05	0.000628	CcSEcCtD
Methadone—Oedema—Dexamethasone—atopic dermatitis	4.26e-05	0.000628	CcSEcCtD
Methadone—OPRM1—head—atopic dermatitis	4.26e-05	0.0356	CbGeAlD
Methadone—Insomnia—Triamcinolone—atopic dermatitis	4.25e-05	0.000626	CcSEcCtD
Methadone—Insomnia—Methylprednisolone—atopic dermatitis	4.24e-05	0.000625	CcSEcCtD
Methadone—Feeling abnormal—Prednisolone—atopic dermatitis	4.21e-05	0.00062	CcSEcCtD
Methadone—Shock—Betamethasone—atopic dermatitis	4.19e-05	0.000618	CcSEcCtD
Methadone—Shock—Dexamethasone—atopic dermatitis	4.19e-05	0.000618	CcSEcCtD
Methadone—Agitation—Prednisone—atopic dermatitis	4.18e-05	0.000616	CcSEcCtD
Methadone—Thrombocytopenia—Betamethasone—atopic dermatitis	4.17e-05	0.000615	CcSEcCtD
Methadone—Thrombocytopenia—Dexamethasone—atopic dermatitis	4.17e-05	0.000615	CcSEcCtD
Methadone—Tachycardia—Betamethasone—atopic dermatitis	4.16e-05	0.000613	CcSEcCtD
Methadone—Tachycardia—Dexamethasone—atopic dermatitis	4.16e-05	0.000613	CcSEcCtD
Methadone—Hyperhidrosis—Dexamethasone—atopic dermatitis	4.12e-05	0.000607	CcSEcCtD
Methadone—Hyperhidrosis—Betamethasone—atopic dermatitis	4.12e-05	0.000607	CcSEcCtD
Methadone—Feeling abnormal—Hydrocortisone—atopic dermatitis	4.11e-05	0.000606	CcSEcCtD
Methadone—Vertigo—Prednisone—atopic dermatitis	4.08e-05	0.000602	CcSEcCtD
Methadone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	4.08e-05	0.000601	CcSEcCtD
Methadone—Syncope—Prednisone—atopic dermatitis	4.08e-05	0.000601	CcSEcCtD
Methadone—Anorexia—Betamethasone—atopic dermatitis	4.06e-05	0.000599	CcSEcCtD
Methadone—Anorexia—Dexamethasone—atopic dermatitis	4.06e-05	0.000599	CcSEcCtD
Methadone—Urticaria—Prednisolone—atopic dermatitis	4.06e-05	0.000598	CcSEcCtD
Methadone—Pain—Triamcinolone—atopic dermatitis	4.01e-05	0.000592	CcSEcCtD
Methadone—Loss of consciousness—Prednisone—atopic dermatitis	4e-05	0.000589	CcSEcCtD
Methadone—Hypotension—Betamethasone—atopic dermatitis	3.98e-05	0.000587	CcSEcCtD
Methadone—Hypotension—Dexamethasone—atopic dermatitis	3.98e-05	0.000587	CcSEcCtD
Methadone—Urticaria—Hydrocortisone—atopic dermatitis	3.96e-05	0.000584	CcSEcCtD
Methadone—Body temperature increased—Hydrocortisone—atopic dermatitis	3.94e-05	0.000581	CcSEcCtD
Methadone—Abdominal pain—Hydrocortisone—atopic dermatitis	3.94e-05	0.000581	CcSEcCtD
Methadone—Convulsion—Prednisone—atopic dermatitis	3.94e-05	0.000581	CcSEcCtD
Methadone—Feeling abnormal—Triamcinolone—atopic dermatitis	3.87e-05	0.00057	CcSEcCtD
Methadone—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.86e-05	0.000569	CcSEcCtD
Methadone—Anxiety—Prednisone—atopic dermatitis	3.86e-05	0.000568	CcSEcCtD
Methadone—Insomnia—Betamethasone—atopic dermatitis	3.85e-05	0.000568	CcSEcCtD
Methadone—Insomnia—Dexamethasone—atopic dermatitis	3.85e-05	0.000568	CcSEcCtD
Methadone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.83e-05	0.000565	CcSEcCtD
Methadone—Hypersensitivity—Prednisolone—atopic dermatitis	3.76e-05	0.000554	CcSEcCtD
Methadone—Urticaria—Triamcinolone—atopic dermatitis	3.73e-05	0.00055	CcSEcCtD
Methadone—Urticaria—Methylprednisolone—atopic dermatitis	3.72e-05	0.000549	CcSEcCtD
Methadone—Body temperature increased—Triamcinolone—atopic dermatitis	3.71e-05	0.000547	CcSEcCtD
Methadone—Oedema—Prednisone—atopic dermatitis	3.71e-05	0.000547	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—atopic dermatitis	3.71e-05	0.000547	CcSEcCtD
Methadone—Abdominal pain—Methylprednisolone—atopic dermatitis	3.7e-05	0.000546	CcSEcCtD
Methadone—Decreased appetite—Dexamethasone—atopic dermatitis	3.7e-05	0.000546	CcSEcCtD
Methadone—Decreased appetite—Betamethasone—atopic dermatitis	3.7e-05	0.000546	CcSEcCtD
Methadone—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.67e-05	0.000542	CcSEcCtD
Methadone—Shock—Prednisone—atopic dermatitis	3.65e-05	0.000538	CcSEcCtD
Methadone—Pain—Betamethasone—atopic dermatitis	3.64e-05	0.000537	CcSEcCtD
Methadone—Pain—Dexamethasone—atopic dermatitis	3.64e-05	0.000537	CcSEcCtD
Methadone—Tachycardia—Prednisone—atopic dermatitis	3.62e-05	0.000534	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—atopic dermatitis	3.59e-05	0.000529	CcSEcCtD
Methadone—Asthenia—Hydrocortisone—atopic dermatitis	3.58e-05	0.000527	CcSEcCtD
Methadone—CYP19A1—head—atopic dermatitis	3.58e-05	0.0299	CbGeAlD
Methadone—Anorexia—Prednisone—atopic dermatitis	3.54e-05	0.000521	CcSEcCtD
Methadone—Pruritus—Hydrocortisone—atopic dermatitis	3.53e-05	0.00052	CcSEcCtD
Methadone—CYP2B6—skin of body—atopic dermatitis	3.52e-05	0.0295	CbGeAlD
Methadone—Feeling abnormal—Betamethasone—atopic dermatitis	3.51e-05	0.000517	CcSEcCtD
Methadone—Feeling abnormal—Dexamethasone—atopic dermatitis	3.51e-05	0.000517	CcSEcCtD
Methadone—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.48e-05	0.000513	CcSEcCtD
Methadone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.48e-05	0.000513	CcSEcCtD
Methadone—Hypersensitivity—Triamcinolone—atopic dermatitis	3.46e-05	0.00051	CcSEcCtD
Methadone—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.45e-05	0.000509	CcSEcCtD
Methadone—Diarrhoea—Hydrocortisone—atopic dermatitis	3.41e-05	0.000503	CcSEcCtD
Methadone—Urticaria—Dexamethasone—atopic dermatitis	3.38e-05	0.000499	CcSEcCtD
Methadone—Urticaria—Betamethasone—atopic dermatitis	3.38e-05	0.000499	CcSEcCtD
Methadone—Dizziness—Prednisolone—atopic dermatitis	3.38e-05	0.000498	CcSEcCtD
Methadone—Asthenia—Triamcinolone—atopic dermatitis	3.37e-05	0.000497	CcSEcCtD
Methadone—Body temperature increased—Dexamethasone—atopic dermatitis	3.37e-05	0.000496	CcSEcCtD
Methadone—Abdominal pain—Betamethasone—atopic dermatitis	3.37e-05	0.000496	CcSEcCtD
Methadone—Body temperature increased—Betamethasone—atopic dermatitis	3.37e-05	0.000496	CcSEcCtD
Methadone—Abdominal pain—Dexamethasone—atopic dermatitis	3.37e-05	0.000496	CcSEcCtD
Methadone—Asthenia—Methylprednisolone—atopic dermatitis	3.36e-05	0.000495	CcSEcCtD
Methadone—Insomnia—Prednisone—atopic dermatitis	3.36e-05	0.000495	CcSEcCtD
Methadone—Pruritus—Triamcinolone—atopic dermatitis	3.32e-05	0.00049	CcSEcCtD
Methadone—Pruritus—Methylprednisolone—atopic dermatitis	3.31e-05	0.000489	CcSEcCtD
Methadone—Dizziness—Hydrocortisone—atopic dermatitis	3.3e-05	0.000486	CcSEcCtD
Methadone—Decreased appetite—Prednisone—atopic dermatitis	3.22e-05	0.000475	CcSEcCtD
Methadone—Rash—Prednisolone—atopic dermatitis	3.22e-05	0.000475	CcSEcCtD
Methadone—Dermatitis—Prednisolone—atopic dermatitis	3.22e-05	0.000474	CcSEcCtD
Methadone—Diarrhoea—Methylprednisolone—atopic dermatitis	3.21e-05	0.000472	CcSEcCtD
Methadone—Headache—Prednisolone—atopic dermatitis	3.2e-05	0.000471	CcSEcCtD
Methadone—Constipation—Prednisone—atopic dermatitis	3.17e-05	0.000468	CcSEcCtD
Methadone—Vomiting—Hydrocortisone—atopic dermatitis	3.17e-05	0.000467	CcSEcCtD
Methadone—Rash—Hydrocortisone—atopic dermatitis	3.14e-05	0.000463	CcSEcCtD
Methadone—Dermatitis—Hydrocortisone—atopic dermatitis	3.14e-05	0.000463	CcSEcCtD
Methadone—Headache—Hydrocortisone—atopic dermatitis	3.12e-05	0.00046	CcSEcCtD
Methadone—Dizziness—Triamcinolone—atopic dermatitis	3.1e-05	0.000458	CcSEcCtD
Methadone—Dizziness—Methylprednisolone—atopic dermatitis	3.1e-05	0.000457	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—atopic dermatitis	3.06e-05	0.000451	CcSEcCtD
Methadone—Asthenia—Betamethasone—atopic dermatitis	3.06e-05	0.000451	CcSEcCtD
Methadone—Asthenia—Dexamethasone—atopic dermatitis	3.06e-05	0.000451	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—atopic dermatitis	3.03e-05	0.000447	CcSEcCtD
Methadone—Nausea—Prednisolone—atopic dermatitis	3.03e-05	0.000447	CcSEcCtD
Methadone—Pruritus—Betamethasone—atopic dermatitis	3.01e-05	0.000444	CcSEcCtD
Methadone—Pruritus—Dexamethasone—atopic dermatitis	3.01e-05	0.000444	CcSEcCtD
Methadone—Vomiting—Triamcinolone—atopic dermatitis	2.99e-05	0.00044	CcSEcCtD
Methadone—Vomiting—Methylprednisolone—atopic dermatitis	2.98e-05	0.000439	CcSEcCtD
Methadone—Nausea—Hydrocortisone—atopic dermatitis	2.96e-05	0.000437	CcSEcCtD
Methadone—Rash—Triamcinolone—atopic dermatitis	2.96e-05	0.000436	CcSEcCtD
Methadone—Dermatitis—Triamcinolone—atopic dermatitis	2.96e-05	0.000436	CcSEcCtD
Methadone—Rash—Methylprednisolone—atopic dermatitis	2.95e-05	0.000435	CcSEcCtD
Methadone—Dermatitis—Methylprednisolone—atopic dermatitis	2.95e-05	0.000435	CcSEcCtD
Methadone—Urticaria—Prednisone—atopic dermatitis	2.95e-05	0.000434	CcSEcCtD
Methadone—Headache—Triamcinolone—atopic dermatitis	2.94e-05	0.000434	CcSEcCtD
Methadone—Headache—Methylprednisolone—atopic dermatitis	2.93e-05	0.000433	CcSEcCtD
Methadone—Abdominal pain—Prednisone—atopic dermatitis	2.93e-05	0.000432	CcSEcCtD
Methadone—Body temperature increased—Prednisone—atopic dermatitis	2.93e-05	0.000432	CcSEcCtD
Methadone—Diarrhoea—Betamethasone—atopic dermatitis	2.91e-05	0.00043	CcSEcCtD
Methadone—Diarrhoea—Dexamethasone—atopic dermatitis	2.91e-05	0.00043	CcSEcCtD
Methadone—Dizziness—Dexamethasone—atopic dermatitis	2.82e-05	0.000415	CcSEcCtD
Methadone—Dizziness—Betamethasone—atopic dermatitis	2.82e-05	0.000415	CcSEcCtD
Methadone—Nausea—Triamcinolone—atopic dermatitis	2.79e-05	0.000411	CcSEcCtD
Methadone—Nausea—Methylprednisolone—atopic dermatitis	2.78e-05	0.00041	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—atopic dermatitis	2.73e-05	0.000403	CcSEcCtD
Methadone—Vomiting—Dexamethasone—atopic dermatitis	2.71e-05	0.000399	CcSEcCtD
Methadone—Vomiting—Betamethasone—atopic dermatitis	2.71e-05	0.000399	CcSEcCtD
Methadone—Rash—Dexamethasone—atopic dermatitis	2.69e-05	0.000396	CcSEcCtD
Methadone—Rash—Betamethasone—atopic dermatitis	2.69e-05	0.000396	CcSEcCtD
Methadone—Dermatitis—Betamethasone—atopic dermatitis	2.68e-05	0.000396	CcSEcCtD
Methadone—Dermatitis—Dexamethasone—atopic dermatitis	2.68e-05	0.000396	CcSEcCtD
Methadone—Headache—Betamethasone—atopic dermatitis	2.67e-05	0.000393	CcSEcCtD
Methadone—Headache—Dexamethasone—atopic dermatitis	2.67e-05	0.000393	CcSEcCtD
Methadone—Asthenia—Prednisone—atopic dermatitis	2.66e-05	0.000392	CcSEcCtD
Methadone—Pruritus—Prednisone—atopic dermatitis	2.62e-05	0.000387	CcSEcCtD
Methadone—Diarrhoea—Prednisone—atopic dermatitis	2.54e-05	0.000374	CcSEcCtD
Methadone—Nausea—Betamethasone—atopic dermatitis	2.53e-05	0.000373	CcSEcCtD
Methadone—Nausea—Dexamethasone—atopic dermatitis	2.53e-05	0.000373	CcSEcCtD
Methadone—Dizziness—Prednisone—atopic dermatitis	2.45e-05	0.000362	CcSEcCtD
Methadone—Vomiting—Prednisone—atopic dermatitis	2.36e-05	0.000348	CcSEcCtD
Methadone—Rash—Prednisone—atopic dermatitis	2.34e-05	0.000345	CcSEcCtD
Methadone—Dermatitis—Prednisone—atopic dermatitis	2.34e-05	0.000344	CcSEcCtD
Methadone—Headache—Prednisone—atopic dermatitis	2.32e-05	0.000343	CcSEcCtD
Methadone—CYP2B6—head—atopic dermatitis	2.3e-05	0.0192	CbGeAlD
Methadone—Nausea—Prednisone—atopic dermatitis	2.2e-05	0.000325	CcSEcCtD
Methadone—CYP2D6—head—atopic dermatitis	1.71e-05	0.0143	CbGeAlD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.55e-05	0.00222	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	1.54e-05	0.00221	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	1.54e-05	0.00221	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	1.54e-05	0.00221	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	1.51e-05	0.00217	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	1.51e-05	0.00217	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	1.51e-05	0.00217	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.5e-05	0.00216	CbGpPWpGaD
Methadone—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	1.49e-05	0.00214	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	1.48e-05	0.00213	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	1.48e-05	0.00212	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	1.44e-05	0.00207	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	1.43e-05	0.00206	CbGpPWpGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.43e-05	0.00205	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	1.4e-05	0.00201	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	1.4e-05	0.00201	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.39e-05	0.002	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	1.38e-05	0.00198	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	1.37e-05	0.00196	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.36e-05	0.00195	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.33e-05	0.00191	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	1.33e-05	0.0019	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	1.3e-05	0.00186	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	1.28e-05	0.00184	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	1.28e-05	0.00184	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.26e-05	0.0018	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	1.25e-05	0.0018	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	1.25e-05	0.00179	CbGpPWpGaD
Methadone—ABCB1—head—atopic dermatitis	1.23e-05	0.0103	CbGeAlD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.22e-05	0.00175	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	1.22e-05	0.00175	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.21e-05	0.00174	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.2e-05	0.00173	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	1.2e-05	0.00173	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	1.2e-05	0.00172	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	1.18e-05	0.00169	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	1.17e-05	0.00167	CbGpPWpGaD
Methadone—HTR3A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.16e-05	0.00166	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.15e-05	0.00165	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	1.12e-05	0.00161	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	1.12e-05	0.0016	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.11e-05	0.0016	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.1e-05	0.00158	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	1.09e-05	0.00157	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GLB1—atopic dermatitis	1.09e-05	0.00156	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	1.07e-05	0.00153	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	1.06e-05	0.00152	CbGpPWpGaD
Methadone—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.06e-05	0.00152	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	1.05e-05	0.00151	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ADSL—atopic dermatitis	1.04e-05	0.0015	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.04e-05	0.00149	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.04e-05	0.00149	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	1.03e-05	0.00148	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.03e-05	0.00148	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.02e-05	0.00146	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.01e-05	0.00146	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	9.96e-06	0.00143	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	9.93e-06	0.00143	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	9.79e-06	0.00141	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	9.75e-06	0.0014	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	9.75e-06	0.0014	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	9.59e-06	0.00138	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	9.56e-06	0.00137	CbGpPWpGaD
Methadone—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	9.5e-06	0.00136	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	9.47e-06	0.00136	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	9.3e-06	0.00134	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	9.3e-06	0.00134	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	9.29e-06	0.00133	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	9.08e-06	0.0013	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	9.06e-06	0.0013	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	9.03e-06	0.0013	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	8.93e-06	0.00128	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	8.9e-06	0.00128	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	8.85e-06	0.00127	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	8.85e-06	0.00127	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	8.81e-06	0.00126	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	8.73e-06	0.00125	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	8.72e-06	0.00125	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	8.71e-06	0.00125	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	8.68e-06	0.00125	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	8.55e-06	0.00123	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	8.55e-06	0.00123	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	8.45e-06	0.00121	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	8.42e-06	0.00121	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—IL2—atopic dermatitis	8.42e-06	0.00121	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.38e-06	0.0012	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GLB1—atopic dermatitis	8.34e-06	0.0012	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	8.33e-06	0.0012	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.28e-06	0.00119	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	8.28e-06	0.00119	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	8.23e-06	0.00118	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	8.11e-06	0.00116	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ADSL—atopic dermatitis	7.99e-06	0.00115	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	7.96e-06	0.00114	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	7.95e-06	0.00114	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	7.86e-06	0.00113	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	7.85e-06	0.00113	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	7.83e-06	0.00112	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	7.76e-06	0.00112	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	7.76e-06	0.00112	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	7.73e-06	0.00111	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	7.61e-06	0.00109	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.54e-06	0.00108	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	7.54e-06	0.00108	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.38e-06	0.00106	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	7.38e-06	0.00106	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	7.36e-06	0.00106	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GLB1—atopic dermatitis	7.24e-06	0.00104	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	7.22e-06	0.00104	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	7.22e-06	0.00104	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	7.22e-06	0.00104	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	7.2e-06	0.00103	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	7.2e-06	0.00103	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	7.08e-06	0.00102	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.08e-06	0.00102	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	7.02e-06	0.00101	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	6.98e-06	0.001	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ADSL—atopic dermatitis	6.94e-06	0.000997	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.78e-06	0.000973	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	6.77e-06	0.000972	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	6.72e-06	0.000965	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	6.65e-06	0.000956	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	6.62e-06	0.000951	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	6.56e-06	0.000942	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	6.56e-06	0.000942	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	6.43e-06	0.000924	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	6.41e-06	0.000921	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	6.31e-06	0.000907	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	6.31e-06	0.000907	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.24e-06	0.000896	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	6.15e-06	0.000884	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—TNF—atopic dermatitis	6.13e-06	0.00088	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	6.1e-06	0.000876	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	6.09e-06	0.000875	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.07e-06	0.000873	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	6.04e-06	0.000868	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	5.99e-06	0.000861	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	5.93e-06	0.000852	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	5.9e-06	0.000847	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	5.87e-06	0.000843	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	5.83e-06	0.000838	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.73e-06	0.000823	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.65e-06	0.000811	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	5.62e-06	0.000808	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.5e-06	0.00079	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	5.44e-06	0.000782	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GLB1—atopic dermatitis	5.35e-06	0.000769	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	5.33e-06	0.000766	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	5.33e-06	0.000766	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	5.3e-06	0.000761	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	5.25e-06	0.000755	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GLB1—atopic dermatitis	5.23e-06	0.000752	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	5.23e-06	0.000751	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NPS—atopic dermatitis	5.23e-06	0.000751	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	5.2e-06	0.000747	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	5.14e-06	0.000739	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ADSL—atopic dermatitis	5.13e-06	0.000737	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	5.13e-06	0.000737	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ADSL—atopic dermatitis	5.02e-06	0.000721	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	5.01e-06	0.00072	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	4.93e-06	0.000708	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL5—atopic dermatitis	4.86e-06	0.000698	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	4.77e-06	0.000685	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	4.75e-06	0.000683	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	4.59e-06	0.000659	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NPS—atopic dermatitis	4.59e-06	0.000659	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GLB1—atopic dermatitis	4.53e-06	0.000651	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	4.5e-06	0.000646	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	4.48e-06	0.000643	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	4.44e-06	0.000638	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	4.35e-06	0.000625	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADSL—atopic dermatitis	4.35e-06	0.000624	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL5—atopic dermatitis	4.26e-06	0.000612	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	4.15e-06	0.000595	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GLB1—atopic dermatitis	4.05e-06	0.000581	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	4.03e-06	0.000579	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GLB1—atopic dermatitis	3.95e-06	0.000567	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADSL—atopic dermatitis	3.88e-06	0.000557	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	3.88e-06	0.000557	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NPS—atopic dermatitis	3.88e-06	0.000557	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.82e-06	0.000549	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.8e-06	0.000546	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADSL—atopic dermatitis	3.79e-06	0.000544	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.72e-06	0.000535	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GLB1—atopic dermatitis	3.69e-06	0.00053	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	3.63e-06	0.000522	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.62e-06	0.00052	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL5—atopic dermatitis	3.6e-06	0.000518	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	3.57e-06	0.000513	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.57e-06	0.000512	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADSL—atopic dermatitis	3.54e-06	0.000508	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PPARA—atopic dermatitis	3.53e-06	0.000508	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	3.46e-06	0.000497	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NGF—atopic dermatitis	3.3e-06	0.000475	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.3e-06	0.000474	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	3.29e-06	0.000473	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	3.21e-06	0.000462	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.18e-06	0.000456	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GLB1—atopic dermatitis	3.15e-06	0.000453	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	3.14e-06	0.000452	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	3.13e-06	0.000449	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	3.07e-06	0.000441	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	3.04e-06	0.000436	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.02e-06	0.000435	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADSL—atopic dermatitis	3.02e-06	0.000434	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.95e-06	0.000423	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NGF—atopic dermatitis	2.9e-06	0.000416	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	2.89e-06	0.000414	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	2.82e-06	0.000405	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	2.76e-06	0.000396	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.74e-06	0.000393	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	2.73e-06	0.000392	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PPARA—atopic dermatitis	2.71e-06	0.000389	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.69e-06	0.000386	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.69e-06	0.000386	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	2.64e-06	0.00038	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.57e-06	0.000369	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NGF—atopic dermatitis	2.45e-06	0.000352	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.44e-06	0.00035	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.43e-06	0.000349	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	2.39e-06	0.000343	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	2.38e-06	0.000342	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PPARA—atopic dermatitis	2.35e-06	0.000337	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.33e-06	0.000335	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	2.33e-06	0.000335	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.3e-06	0.00033	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.02e-06	0.00029	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.94e-06	0.000279	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2—atopic dermatitis	1.86e-06	0.000267	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	1.85e-06	0.000265	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.74e-06	0.00025	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.71e-06	0.000246	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.7e-06	0.000245	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARA—atopic dermatitis	1.7e-06	0.000244	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.63e-06	0.000234	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.62e-06	0.000233	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.5e-06	0.000215	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.47e-06	0.000211	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.44e-06	0.000207	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—atopic dermatitis	1.38e-06	0.000198	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	1.37e-06	0.000197	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.31e-06	0.000189	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARA—atopic dermatitis	1.28e-06	0.000184	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.27e-06	0.000182	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.21e-06	0.000173	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.2e-06	0.000172	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.09e-06	0.000157	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.02e-06	0.000147	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—atopic dermatitis	9.57e-07	0.000138	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—atopic dermatitis	8.09e-07	0.000116	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARA—atopic dermatitis	7.9e-07	0.000113	CbGpPWpGaD
